Cimzia (Certolizumab)

Cimzia (certolizumab) is a biologic medicine that helps the pain and swelling of arthritis. It works by blocking TNF (Tumor Necrosis Factor), a type of signalling protein (called a cytokine), that is involved in systemic inflammation.

Cimzia belongs to a class of similar medications called “Anti-TNF” agents.

Cimzia is used to treat Rheumatoid Arthritis and Crohn’s Disease.

Taking Cimzia

Cimzia is available in pre-filled syringes that are usually taken once every 2 weeks. The normal dose is 400 mg every 2 weeks for the first 3 doses, then 200 mg every 2 weeks after that.

Although some patients can feel better quite quickly in others it can take a little longer. Patients starting Cimizia should continue taking the medication as prescribed.

To learn how take Cimzia at home, watch our video: Learn how to inject: subcutaneous injections. Subcutaneous injections are easy to do compared to other types of injections. A small needle pokes just under the skin to deliver medicine into the “fatty tissue” below.

Important Tests and Risks

Cimzia can make it a bit harder for people to fight off infections. Patients taking this medicine should call their doctor they have a fever, think they have an infection, or have been prescribed antibiotics to treat an infection.

Patients should coordinate with their doctor to stop treatment before any surgery. It can be re-started once things have healed and there’s no sign of infection.

Patients should discuss all vaccinations with their doctor because some are not advisable to get while taking Cimzia.

It is important to get a TB (tuberculosis) skin test and a chest x-ray before starting Cimzia.

Drug Identification Number (DIN): 02331675 (SC)